Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Innoviva Inc (INVA)  
$15.26 0.27 (1.8%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 101,390,000
Market Cap: 1.55(B)
Last Volume: 668,805 Avg Vol: 666,939
52 Week Range: $11.44 - $16.78
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Innoviva is a company with a portfolio of royalties and other healthcare assets. Co.'s royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and TRELEGY® ELLIPTA®. Co. is entitled to royalty payments made by GSK under its agreements that assigned to Theravance Respiratory Company, LLC (TRC), including TRELEGY® ELLIPTA® and any other product or combination of products that may be discovered or developed in the future under the Long-Acting Beta2 Agonist Collaboration Agreement and the Strategic Alliance Agreement with GSK, which have been assigned to TRC other than RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 661,000 664,000
Total Buy Value $0 $0 $8,435,402 $8,468,005
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 11 12
Total Shares Sold 0 10,994 10,994 10,994
Total Sell Value $0 $153,810 $153,810 $153,810
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 283
  Page 6 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kostas Odysseas D Director   –       •      –    2017-12-19 4 A $0.00 $0 D/D 14,513 14,513     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2017-12-04 4 S $13.13 $157,791 D/D (12,022) 980,907     -
   Desparbes Eric SVP and CFO   •       –      –    2017-11-21 4 AS $13.31 $179,171 D/D (13,460) 321,742     -
   Abercrombie George B Sr. VP & Chief Comm. Officer   •       –      –    2017-11-21 4 AS $13.26 $69,145 D/D (5,215) 258,651     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2017-11-21 4 AS $13.29 $172,795 D/D (13,000) 213,800     -
   Faerm Michael E. Sr VP & Chief Business Officer   •       –      –    2017-11-20 4 D $13.17 $58,870 D/D (4,470) 279,422     -
   Desparbes Eric SVP and CFO   •       –      –    2017-11-20 4 AS $13.04 $23,798 D/D (1,825) 335,202     -
   Desparbes Eric SVP and CFO   •       –      –    2017-11-20 4 D $13.17 $80,877 D/D (6,141) 337,027     -
   Abercrombie George B Sr. VP & Chief Comm. Officer   •       –      –    2017-11-20 4 D $13.17 $44,225 D/D (3,358) 263,866     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2017-11-20 4 D $13.17 $566,810 D/D (43,038) 992,929     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2017-11-20 4 D $13.17 $194,350 D/D (14,757) 226,800     -
   Desparbes Eric SVP and CFO   •       –      –    2017-08-21 4 AS $12.20 $22,265 D/D (1,825) 343,168     -
   Faerm Michael E. Sr VP & Chief Business Officer   •       –      –    2017-08-20 4 D $12.28 $39,038 D/D (3,179) 283,892     -
   Desparbes Eric SVP and CFO   •       –      –    2017-08-20 4 D $12.28 $70,856 D/D (5,770) 344,993     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2017-08-20 4 D $12.28 $158,621 D/D (12,917) 1,035,967     -
   Abercrombie George B Sr. VP & Chief Comm. Officer   •       –      –    2017-08-20 4 D $12.28 $35,440 D/D (2,886) 267,224     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2017-08-20 4 D $12.28 $31,879 D/D (2,596) 241,557     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2017-05-22 4 S $12.01 $93,858 D/D (7,815) 244,153     -
   Desparbes Eric SVP and CFO   •       –      –    2017-05-22 4 AS $11.85 $21,626 D/D (1,825) 350,763     -
   Abercrombie George B Sr. VP & Chief Comm. Officer   •       –      –    2017-05-20 4 D $11.86 $26,424 D/D (2,228) 270,110     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2017-05-20 4 D $11.86 $30,717 D/D (2,590) 251,968     -
   Desparbes Eric SVP and CFO   •       –      –    2017-05-20 4 D $11.86 $49,907 D/D (4,208) 352,588     -
   Faerm Michael E. Sr VP & Chief Business Officer   •       –      –    2017-05-20 4 D $11.86 $37,667 D/D (3,176) 287,071     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2017-05-20 4 D $11.86 $152,958 D/D (12,897) 1,048,884     -
   Lepore Patrick G Director   –       •      –    2017-04-20 4 A $0.00 $0 D/D 19,857 58,278     -
  283 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us